OR WAIT null SECS
March 04, 2015
Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.
March 03, 2015
A facility expansion adds space for production of Repligen’s tangential flow system.
Novasep has entered into an agreement with Celladon to provide scale-up and pre-validation studies for the drug substance for MYDICAR.
March 02, 2015
Protecting workers, patients, and the environment requires advanced technologies.
February 01, 2015
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.
August 02, 2014
Annual study shows CMO technical expertise is not enough.
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
August 01, 2014
Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.
Contract service providers describe how quality by design has influenced a drug sponsor's expectations of suppliers.
Representatives of contract service organizations that develop biologic-based drugs discussed technology trends such as high-throughput screening and single-use systems.